Advanced Medical Isotope Return On Tangible Equity 2013-2024 | RDGL

Advanced Medical Isotope return on tangible equity from 2013 to 2024. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.

Advanced Medical Isotope Return On Tangible Equity 2013-2024 | RDGL

Advanced Medical Isotope return on tangible equity from 2013 to 2024. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Related Stocks
Company NameMarket
Cap
Ares Capital (ARCC)$13.1B
Blackstone Secured Lending Fund (BXSL)$6.1B
FS KKR Capital (FSK)$5.5B
Main Street Capital (MAIN)$4.4B
Hercules Capital (HTGC)$3.2B
Golub Capital BDC (GBDC)$2.6B
Morgan Stanley Direct Lending Fund (MSDL)$1.8B
Goldman Sachs BDC (GSBD)$1.7B
New Mountain Finance (NMFC)$1.3B
Kayne Anderson BDC (KBDC)$1.2B
Bain Capital Specialty Finance (BCSF)$1.1B
BARINGS BDC, INC (BBDC)$1.1B
Amalgamated Financial (AMAL)$1B
Nuveen Churchill Direct Lending (NCDL)$981M
Carlyle Secured Lending (CGBD)$889M
SLR Investment (SLRC)$829M
Trinity Capital (TRIN)$754M
BLACKROCK TCP CAPITAL CORP (TCPC)$724M
Crescent Capital BDC (CCAP)$703M
Fidus Investment (FDUS)$650M
CION Investment (CION)$645M
Palmer Square Capital BDC (PSBD)$534M
Gladstone Capital (GLAD)$511M
Gladstone Investment (GAIN)$500M
PennantPark Investment (PNNT)$455M
Runway Growth Finance (RWAY)$400M
Horizon Technology Finance (HRZN)$389M
Stellus Capital Investment (SCM)$356M
Saratoga Investment Corp (SAR)$321M
TriplePoint Venture Growth BDC (TPVG)$290M